New Key Statistics Module, Z-Score and F-Score
OTCPK:ENTBF Key Ratios
| Market Cap $ M | 1.11 |
| Enterprise Value $ M | 0.92 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 4.15 |
| Price/Sales | 7.73 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.03 |
| Beneish M-Score | -3.89 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 21.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -4.47 |
| EV-to-EBITDA | -4.47 |
| PEG | -- |
| Shares Outstanding M | 8.86 |
| Net Margin (%) | -215.39 |
| Operating Margin % | -216.15 |
| Pre-tax Margin (%) | -215.39 |
| Quick Ratio | 5.63 |
| Current Ratio | 5.63 |
| ROA % (ttm) | -59.10 |
| ROE % (ttm) | -71.76 |
| ROIC % (ttm) | -1,898.65 |
| Dividend Yield % | -- |
| Altman Z-Score | -86.55 |
ENTBF Number of Guru Trades
ENTBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ENTBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ENTBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Entheon Biomedical Corp Insider Transactions
No Available Data
News about OTCPK:ENTBF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers